Skip to main content

Table 5 Intermediate precision of valsartan and metformin

From: Valsartan in combination with metformin and gliclazide in diabetic rat model using developed RP-HPLC method

No. of injections

Metformin (30 μg.ml1) area

Valsartan (10 μg.ml1) area

Days

Days

1

2

3

Average

1

2

3

Average

1

6218.0

6111.0

6105.0

6145.0

16126.0

16010.0

15994.0

16043.0

2

6128.0

6221.0

6215.0

6188.0

16172.0

16156.0

16040.0

16122.0

3

6218.0

6131.0

6225.0

6191.0

16175.0

16158.0

16142.0

16158.0

4

6136.0

6130.0

6123.0

6130.0

16159.0

16142.0

16126.0

16142.0

5

6160.0

6153.0

6247.0

6187.0

16080.0

16264.0

16148.0

16164.0

6

6206.0

6199.0

6193.0

6199.0

16165.0

16148.0

16232.0

16182.0

SD

41.360

43.450

57.670

28.750

36.886

80.850

84.715

49.519

Mean

6177.6

6157.0

6185.0

6173.2

16146.1

16146.3

16113.6

16135.1

RSD (%)

0.67

0.706

0.93

0.466

0.228

0.5

0.527

0.306

  1. μg.ml−1, microgram per milliliter; SD, standard deviation; %RSD, the percentage of relative standard deviation